Mave Health raises $2.1M
Mave Health raised $2.1M for a wearable headset that boosts focus and reduces stress — early trials showed a 72% remission rate and the device is already used at Google, UFC and Y Combinator. (x.com)
The seed round was led by Blume Ventures, with participation from Stanford Angels and angel investors such as Dhaval Shroff and Raymond Russell. (businesswire.com) Mave says it completed a 500-person beta prior to launch, testing the headset’s usability and program flow. (businesswire.com) The company was founded in 2023 by Dhawal Jain (co‑founder & CEO), Jai Sharma (CMO) and Aman Kumar (CTO). (techcrunch.com) Mave’s product uses low‑intensity transcranial direct current stimulation (tDCS) targeted at the prefrontal cortex, delivering roughly 1–2 mA in daily ~20‑minute sessions, according to the company’s science page. (mavehealth.com) The headset is listed for a $495 pre‑order and the company told press it expects to begin shipping to customers in the U.S. and India in April 2026. (msn.com) Before this round Mave raised an earlier pre‑seed of about INR 6 crore and has promoted a 12‑week cohort program in India priced around INR 20,000 per participant. (economictimes.indiatimes.com (inc42.com)
